Europe L-carnitine Market Size & Outlook, 2020-2028
Europe l-carnitine market, 2017-2028 (US$M)
Related Markets
Europe l-carnitine market highlights
- The Europe l-carnitine market generated a revenue of USD 52.4 million in 2020.
- The market is expected to grow at a CAGR of 4.9% from 2021 to 2028.
- In terms of segment, bioprocess was the largest revenue generating process in 2020.
- Bioprocess is the most lucrative process segment registering the fastest growth during the forecast period.
- Country-wise, France is expected to register the highest CAGR from 2021 to 2028.
Europe data book summary
| Market revenue in 2020 | USD 52.4 million |
| Market revenue in 2028 | USD 76.6 million |
| Growth rate | 4.9% (CAGR from 2020 to 2028) |
| Largest segment | Bioprocess |
| Fastest growing segment | Bioprocess |
| Historical data covered | 2017 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Chemical Synthesis, Bioprocess |
| Key market players worldwide | Lonza Group Ltd, Neogen Corp, WuXi Biologics (Cayman) Inc, Merck KGaA, Tokyo Chemical Industry, CEVA Inc |
Other key industry trends
- In terms of revenue, Europe region accounted for 28.3% of the global l-carnitine market in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 69.3 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
L-carnitine Market Scope
L-carnitine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe l-carnitine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to l-carnitine market will help companies and investors design strategic landscapes.
Bioprocess was the largest segment with a revenue share of 76.53% in 2020. Horizon Databook has segmented the Europe l-carnitine market based on chemical synthesis, bioprocess covering the revenue growth of each sub-segment from 2017 to 2028.
Nutraceutical industry in Europe is expected to grow due to an increase in the purchase of supplements as a preventive approach to health concerns. In addition, consumers prefer herbal products over pharmaceuticals due to the latter’s side effects.
The growing acceptance of nutraceuticals to improve health without causing any potential risk of health issues is expected to propel the growth of L-carnitine market over the forecast period. The increased consumption of meat in European countries such as Germany and the UK is expected to promote the use of feed to enhance the growth and health of the animals.
Increase in the demand for swine feed is expected to boost the demand for L-carnitine. L-carnitine helps in promoting the growth of pigs and enhances the reproductive process. Rise in the demand for swine feed in Germany is further expected to propel the growth of L-carnitine market.
Reasons to subscribe to Europe l-carnitine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe l-carnitine market databook
-
Our clientele includes a mix of l-carnitine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe l-carnitine market , including forecasts for subscribers. This continent databook contains high-level insights into Europe l-carnitine market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Europe l carnitine market size, by country, 2017-2028 (US$M)
Europe L-carnitine Market Outlook Share, 2020 & 2028 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
